What is the starting dose of Baclofen (Lioresal) for treating spasticity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Baclofen Starting Dose for Spasticity

The recommended starting dose of baclofen (Lioresal) for treating spasticity is 5 mg up to three times daily. 1

Dosing Guidelines

  • Initial dosing should be conservative at 5 mg up to three times daily to minimize side effects and optimize tolerability, especially in older adults 1
  • Titration should be gradual, as older persons rarely tolerate doses greater than 30 to 40 mg per day 1
  • For severe spasticity unresponsive to oral medications, intrathecal baclofen may be considered as an alternative delivery method 2

Monitoring and Precautions

  • Closely monitor for muscle weakness, urinary function changes, cognitive effects, and sedation during baclofen therapy 1
  • Avoid abrupt discontinuation of baclofen as it can cause central nervous system irritability and potentially severe withdrawal symptoms 1
  • Be particularly cautious when using baclofen in elderly patients who may be more sensitive to side effects 3

Side Effects to Watch For

  • Common adverse effects include sedation, somnolence, excessive weakness, vertigo, and psychological disturbances 4
  • The incidence of adverse effects ranges from 10% to 75%, with most being dose-related, transient, and/or reversible 4
  • Higher doses (>60 mg/day) are associated with increased risk of adverse effects 4

Alternative Medications for Spasticity

  • Tizanidine (Zanaflex) may be considered as an alternative with a starting dose of 2 mg up to three times daily 1
  • For focal spasticity, botulinum toxin may be more effective than oral baclofen 3, 2
  • For generalized spasticity, if long-term continuous effect is needed, baclofen may be more suitable due to its longer duration of action 2

Special Considerations

  • In patients with renal impairment, baclofen should be used with caution as it may carry an unnecessarily high risk 4
  • For patients with severe spasticity who don't respond to or cannot tolerate oral baclofen, intrathecal baclofen therapy may be considered 5
  • Paradoxical worsening of spasticity has been reported with higher doses in some patients, suggesting that lower doses may sometimes be more effective 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tizanidine vs Baclofen for Muscle Spasticity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Baclofen Use in Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intrathecal baclofen pump for spasticity: an evidence-based analysis.

Ontario health technology assessment series, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.